TY - GEN
T1 - Signalling pathways in cardiac regeneration
AU - Santini, Maria Paola
AU - Winn, Nadine
AU - Rosenthal, Nadia
PY - 2006
Y1 - 2006
N2 - Regeneration is a homeostatic mechanism evolved to maintain or restore the original architecture of a damaged tissue by recapitulating part of its original embryonic development. Our focus has been to intervene in signalling mechanisms at work in the regeneration process to increase the efficiency of mammalian tissue repair. In response to traumatic injury, both skeletal and cardiac muscle activate signalling cascades involved in inflammation, cell death and fibrosis, often at the expense of cell survival and regeneration. In contrast, mice expressing a local isoform of insulin-like growth factor 1 (mIGF1) as a muscle-specific transgene maintain skeletal muscle integrity and ageing, counter muscle decline in degenerative muscle disease, and show enhanced stem cell homing to damaged muscle. Under the control of a cardiac-specific promoter, the mIGF1 transgene directs efficient repair of infarcted heart tissue without scar formation. In both models, novel signalling pathways are employed, suggesting specific mechanisms through which mIGF1 improves regeneration and providing potential targets for clinical intervention.
AB - Regeneration is a homeostatic mechanism evolved to maintain or restore the original architecture of a damaged tissue by recapitulating part of its original embryonic development. Our focus has been to intervene in signalling mechanisms at work in the regeneration process to increase the efficiency of mammalian tissue repair. In response to traumatic injury, both skeletal and cardiac muscle activate signalling cascades involved in inflammation, cell death and fibrosis, often at the expense of cell survival and regeneration. In contrast, mice expressing a local isoform of insulin-like growth factor 1 (mIGF1) as a muscle-specific transgene maintain skeletal muscle integrity and ageing, counter muscle decline in degenerative muscle disease, and show enhanced stem cell homing to damaged muscle. Under the control of a cardiac-specific promoter, the mIGF1 transgene directs efficient repair of infarcted heart tissue without scar formation. In both models, novel signalling pathways are employed, suggesting specific mechanisms through which mIGF1 improves regeneration and providing potential targets for clinical intervention.
UR - https://www.scopus.com/pages/publications/39049187712
M3 - Conference contribution
C2 - 17019815
AN - SCOPUS:39049187712
SN - 9780470015971
T3 - Novartis Foundation Symposium
SP - 228
EP - 238
BT - Heart Failure
ER -